Company intelligence / Profile preview

AlpalifeBio

Woburn, Massachusetts, United Statesalpalifebio.com ↗

Ownership: Private
Employees: ~100
Development stage: Other

Overview

AlpalifeBio offers customized VHH/nanobody drug R&D services including discovery, humanization, affinity maturation, cell-based functional studies, GPCR expression/purification/structural determination. The company has delivered hundreds of high-affinity nanobody candidates to global biopharma clients but does not appear to have its own clinical-stage pipeline. No direct clinical results are reported as the company operates primarily as a service provider.

Therapeutic areas: Other
Modalities: Nanobodies (VHH/single-domain antibodies)Recombinant proteins
Industry: Drug Discovery Services

Partnerships

Provides services to top biopharma companies in the United States, Germany, Belgium, Australia, China, Japan, Thailand, South Korea; specific partners not named.

Beyond the preview

Go deeper on AlpalifeBio.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on AlpalifeBio.

Explore the full profile